MedRhythms, a company developing next-gen neurotherapeutics to improve walking, mobility, and related functional outcomes, has named Larry Jasinski as its new CEO, effective immediately.

MedRhythms co-founder Brian Harris will transition to chief scientific officer (CSO) and work with Jasinski to build the market and grow the company in its next phase.

Jasinski touts over 30 years of executive leadership in the medical device and neurotechnology industries. He was most recently CEO of Lifeward (formerly ReWalk Robotics), where he led the company through a successful IPO and gained national reimbursement for the first exoskeleton system for spinal cord injury.

Before that, he was president and CEO of Soteira, which was acquired by Globus Medical in 2012.

“MedRhythms has innovative fundamental technology, well-established published clinical data on effectiveness, an elegant and easy-to-use product with good margins, will operate in sizable market segments and has gained CMS and other coverage,” said Jasinski. “MedRhythms will improve many lives and is positioned to become a valuable business entity. I’m honored to join this mission-driven team and look forward to accelerating our growth and impact on patients’ lives.”

The company is preparing for national expansion of its home-use products for walking impairments: InTandem for chronic stroke and Movive for Parkinson’s disease. Both are FDA-listed devices now available for distribution.

“MedRhythms was founded on the vision and mission of transforming patients’ lives and Larry has dedicated his career to that same mission,” said Harris. “His experience is an ideal fit for the next important phase of the company, and I look forward to working with him to continue to advance the company’s mission and increase its impact in bringing important care to patients who need and deserve it.”